drugset / Trial / NCT03827590

Clinical Trials to Assess the Efficacy and Safety of HLIM

NCT03827590 ↗

Phase 3 Unknown 487 enrolled SamA Pharmaceutical Co., Ltd
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of HLIM

Timeline

Start
2018-11-29
Primary completion
2019-05-30
Completion
2019-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject HLIM Unknown — —
Comparator SA160021 Unknown — —
Comparator SA160022 Unknown — —